Search Results - "Antoneeva, Inna"

The Detection of Stem-Like Circulating Tumor Cells Could Increase the Clinical Applicability of Liquid Biopsy in Ovarian Cancer by Gening, Snezhanna O., Abakumova, Tatyana V., Gafurbaeva, Dina U., Rizvanov, Albert A., Antoneeva, Inna I., Miftakhova, Regina R., Peskov, Andrey B., Gening, Tatyana P.

“…Stem properties allow circulating tumor cells (CTCs) to survive in the bloodstream and initiate cancer progression. We aimed to assess the numbers of stem-like…”
Get full text

Cytokine Status of Serum in Ovarian Cancer Patients with Different Tumor Neoadjuvant Chemotherapy Response by Antoneeva, Inna I, Abakumova, Tatyana V, Dolgova, Dinara R, Gening, Tatyana P, Pirmamedova, Sabina S, Myasnikova, Dinara F, Gening, Snezhanna O

“…Polychemotherapy in ovarian cancer (OC) is the second major component of treatment. However, treatment with cytostatics is stopped in 25% of cases because of…”
Get more information

Effects of CAP-regimen Chemotherapy on Blood Redox Status in Patients with Ovarian Cancer by Antoneeva, Inna I, Dolgova, Dinara R, Gening, Tatyana P, Abakumova, Tatyana V, Gening, Snezhanna O, Pirmamedova, Sabina S, Fomina, Anastasia V, Mikheenko, Alla A

“…Ovarian cancer (OC) is the most lethal of gynecologic tumors because women generally present with advanced stage disease. Platinum-based chemotherapy play a…”
Get more information

The Plasticity of Circulating Tumor Cells in Ovarian Cancer During Platinum-containing Chemotherapy by Gening, Snezhanna Olegovna, Dolgova, Dinara Rishatovna, Abakumova, Tatyana Vladimirovna, Antoneeva, Inna Ivanovna, Gening, Tatyana Petrovna

“…Circulating Tumor Cells (CTCs) are a potential source of metastases and relapses. The data on molecular characteristics of Ovarian Cancer (OC) CTCs are…”
Get more information

Stem-like markers in the circulating tumor cells assessment in ovarian cancer by Gening, Snezhanna, Abakumova, Tatyana, Antoneeva, Inna, Gening, Tatyana

“…Abstract only e17542 Background: Circulating tumor cells (CTCs) are a potential source of dissemination and relapse in ovarian cancer (OC). Stem cell…”
Get full text

Predictive value of inflammatory regulators TGFb1 and CXCL8 in tumor tissue in colorectal cancer by Bogomolova, I. A., Dolgova, D. R., Antoneeva, I. I., Abakumova, T. V., Myagdieva, I. R., Peskov, A. B., Gening, T. P.

“…Background. Colorectal cancer is ranked third in terms of incidence and second in terms of mortality around the world. Molecular markers of chemoresistance…”
Get full text

Parameters of the glutathione system and thioredoxin in blood plasma and ascites and GSTP1 Ile105Val gene polymorphism as factors of resistance to platinum-containing chemotherapy in ovarian cancer patients by Dolgova, D. R., Gening, T. R., Abakumova, T. V., Gening, S. O., Antoneeva, I. I., Fedotova, A. Yu

“…Background. Chemotherapy is one of the main types of treatment in ovarian cancer. Standard first-line treatment includes platinum drugs. Every fifth patient…”
Get full text

RELATIONSHIP BETWEEN THE BLOOD LEVELS OF INFLAMMATORY CYTOKINES AND THE NUMBER OF CIRCULATING TUMOR CELLS WITH RESPONSE TO STANDARD CHEMOTHERAPY IN PATIENTS WITH OVARIAN CANCER by Gening, S. O., Rizvanov, A. A., Abakumova, T. V., Dolgova, D. R., Gafurbaeva, D. U., Rakhmatullina, A. R., Antoneeva, I. I., Gening, T. P.

“…Introduction . Serum chemokines are inflammatory mediators, which role is shown in the occurrence and progression of a number of malignant tumors. Produced by…”
Get full text